ATE65403T1 - Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit. - Google Patents
Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit.Info
- Publication number
- ATE65403T1 ATE65403T1 AT87100811T AT87100811T ATE65403T1 AT E65403 T1 ATE65403 T1 AT E65403T1 AT 87100811 T AT87100811 T AT 87100811T AT 87100811 T AT87100811 T AT 87100811T AT E65403 T1 ATE65403 T1 AT E65403T1
- Authority
- AT
- Austria
- Prior art keywords
- human
- promoting
- csf
- haematopoietic
- restoration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1028086 | 1986-01-22 | ||
| EP87100811A EP0230980B2 (de) | 1986-01-22 | 1987-01-21 | Pharmazeutischer Stoff für die Förderung der Wiederherstellung der hämatopoietischen Fähigkeit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE65403T1 true ATE65403T1 (de) | 1991-08-15 |
Family
ID=11745897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87100811T ATE65403T1 (de) | 1986-01-22 | 1987-01-21 | Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit. |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0230980B2 (de) |
| AT (1) | ATE65403T1 (de) |
| CA (1) | CA1297004C (de) |
| DE (1) | DE3771509D1 (de) |
| ES (1) | ES2039209T5 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5718893A (en) * | 1984-04-15 | 1998-02-17 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
| WO1992011022A1 (fr) * | 1990-12-25 | 1992-07-09 | Kyowa Hakko Kogyo Co., Ltd. | Preparation pharmaceutique destinee a une administration par voie nasale |
| FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| US5536495A (en) * | 1994-04-15 | 1996-07-16 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
| US6495365B1 (en) * | 1996-08-13 | 2002-12-17 | Fujisawa Pharmaceutical Co., Ltd. | Hematopoietic stem cell proliferating agents |
| DE19860801A1 (de) * | 1998-12-30 | 2000-07-06 | Rhein Biotech Proz & Prod Gmbh | Rekombinanter Wachstumsfaktor mit der biologischen Aktivität eines G-CSF (Granulocyte Colony Stimulating Factor) |
| US6646110B2 (en) | 2000-01-10 | 2003-11-11 | Maxygen Holdings Ltd. | G-CSF polypeptides and conjugates |
| US6831158B2 (en) | 2000-01-10 | 2004-12-14 | Maxygen Holdings Ltd. | G-CSF conjugates |
| US6555660B2 (en) | 2000-01-10 | 2003-04-29 | Maxygen Holdings Ltd. | G-CSF conjugates |
| CA2405550A1 (en) | 2000-04-12 | 2001-10-25 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US8435939B2 (en) | 2000-09-05 | 2013-05-07 | Biokine Therapeutics Ltd. | Polypeptide anti-HIV agent containing the same |
| IL159524A0 (en) | 2001-07-11 | 2004-06-01 | Maxygen Holdings Ltd | G-csf conjugates |
| AU2002364586A1 (en) | 2001-12-21 | 2003-07-30 | Delta Biotechnology Limited | Albumin fusion proteins |
| US7423007B2 (en) | 2002-08-27 | 2008-09-09 | Biokine Therapeutics Ltd. | Cxcr4 antagonist and use thereof |
| CA2513213C (en) | 2003-01-22 | 2013-07-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| AU2006254543A1 (en) | 2005-06-01 | 2006-12-07 | Maxygen Holdings Ltd. | PEGylated G-CSF polypeptides and methods of producing same |
| CA2673484A1 (en) | 2006-12-21 | 2008-06-26 | Biokine Therapeutics Ltd. | T-140 peptide analogs having cxcr4 super-agonist activity for cancer therapy |
| US9155780B2 (en) | 2009-02-11 | 2015-10-13 | Yeda Research And Development Co. Ltd. | Short beta-defensin-derived peptides |
| WO2010146578A2 (en) | 2009-06-14 | 2010-12-23 | Biokine Therapeutics Ltd. | Peptide therapy for increasing platelet levels |
| US9439942B2 (en) | 2012-04-24 | 2016-09-13 | Biokine Therapeutics Ltd. | Peptides and use thereof in the treatment of large cell lung cancer |
| DE102014001250C5 (de) | 2014-02-03 | 2021-07-29 | Carl Freudenberg Kg | Fensterwischer |
| CA2986705A1 (en) | 2015-07-16 | 2017-01-19 | Biokine Therapeutics Ltd. | A cxcr4 inhibitor and a pdi antagonist for use in treating cancer |
| EP3419645B1 (de) | 2016-02-23 | 2020-09-02 | BioLineRx Ltd. | Verfahren zur festlegung eines behandlungsplans für akute myeloische leukämie |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61227526A (ja) * | 1984-07-25 | 1986-10-09 | Chugai Pharmaceut Co Ltd | 新規なコロニー刺激因子 |
| EP0215126B1 (de) * | 1985-02-08 | 1991-07-31 | Chugai Seiyaku Kabushiki Kaisha | Menschlicher granuloxcyt-kolonie-stimulierungsfaktor |
-
1987
- 1987-01-21 AT AT87100811T patent/ATE65403T1/de not_active IP Right Cessation
- 1987-01-21 DE DE8787100811T patent/DE3771509D1/de not_active Expired - Lifetime
- 1987-01-21 ES ES87100811T patent/ES2039209T5/es not_active Expired - Lifetime
- 1987-01-21 CA CA000527852A patent/CA1297004C/en not_active Expired - Lifetime
- 1987-01-21 EP EP87100811A patent/EP0230980B2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2039209T5 (es) | 1996-07-16 |
| CA1297004C (en) | 1992-03-10 |
| EP0230980A2 (de) | 1987-08-05 |
| EP0230980B2 (de) | 1996-03-20 |
| EP0230980A3 (en) | 1988-07-27 |
| DE3771509D1 (de) | 1991-08-29 |
| ES2039209T3 (es) | 1993-09-16 |
| EP0230980B1 (de) | 1991-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE65403T1 (de) | Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit. | |
| DE3683430D1 (de) | Einen menschlichen granulozytkoloniereizfaktor fuer die behandlung von leukopenien enthaltende pharmazeutische zubereitung. | |
| ATE74272T1 (de) | Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie. | |
| SE8501050D0 (sv) | Biologically active fragments of human antihemophilic factor and method for preparation thereof | |
| DE69333321D1 (de) | Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten. | |
| ATE227587T1 (de) | Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts | |
| IL78553A (en) | Therapeutic compositions of phosphonylmethoxyalkyl adenines | |
| EP0177910A3 (de) | Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur systemischen Behandlung von verschiedenen Erkrankungen des Menschen in niedriger Dosierung | |
| EP0151989A3 (en) | Means for the treatment of cardiac diseases | |
| NZ281482A (en) | The stimulation of erythropoiesis using thrombopoietin and erythropoietin | |
| OA09317A (fr) | "Utilisation d'un polypeptide ayant l'activité de l'interleukine 2 humaine pour la préparation de compositions pharmaceutiques destinées au traitement des leucémies". | |
| DK12990D0 (da) | Human granulocyt-makrofag-kolonistimulerende faktor og muteiner heraf | |
| NZ224116A (en) | Compositions of interleukin-2 and fk565; method of stimulation of the immune system and package | |
| DE3771584D1 (de) | Zusammensetzungen und anwendung von interleukin-2 und/oder interferon-beta und des tumor-necrosis-faktors fuer eine kombinationstherapie oder zur herstellung von arzneimitteln oder formulierungen. | |
| DE3689921D1 (de) | Menschlicher plazentarer angiogenischer Faktor, geeignet für die Reizung der Kapillarsynthese, der Endothelzellprotease, der DNS-Synthese und der Absiedlung. | |
| ES8603270A1 (es) | Procedimiento para preparar liposomas que contiene alergenoso fracciones de alergenos inhalables | |
| ATA269387A (de) | Pharmazeutisches mittel zur förderung und stimulierung des haarwachstums und zur verringerung von haarausfall auf basis von pyrimidinderivaten, sowie verwendung des mittels | |
| DE69919969D1 (de) | Humanes Wachstumshormon zur Stimulierung der Hämatopoese und der Immunrekonstitution nach hämatopoetischer Stammzelltransplantation beim Menschen | |
| ATE66375T1 (de) | Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung. | |
| ES8704903A1 (es) | Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido. | |
| ATE206056T1 (de) | Therapeutisches agens für neutropenie | |
| Seki et al. | Induction of eosinophil chemotactic factor production from human peripheral blood mononuclear cells by solubilized BALL-1, a B cell lymphoma line | |
| ATE65404T1 (de) | Zusammensetzungen und anwendung von interleukin-2 und/oder interferon-beta und des tumor-necrosis- faktors fuer eine kombinationstherapie oder zur herstellung von arzneimitteln oder formulierungen. | |
| IT8220835A0 (it) | Preparazione di soluzioni iniettabili di actinina impiegabili nella terapia umana come antalgico per il trattamento del dolore da neoplasie ed altre affezioni. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |